Enprofylline is primarily used as a bronchodilator in the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscles in the airways, which helps to improve airflow and reduce symptoms like wheezing, shortness of breath, and coughing. Unlike some other bronchodilators, enprofylline has a unique mechanism of action, as it acts as a selective adenosine receptor antagonist, which contributes to its effectiveness in managing respiratory disorders. Additionally, it has been studied for its potential anti-inflammatory properties, which could further benefit patients with chronic respiratory issues. Its use is typically guided by medical professionals to ensure optimal therapeutic outcomes.